Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaihu Qianzheng San is a Traditional Chinese Medicine (TCM) herbal formula primarily used for the treatment of facial paralysis, such as Bell's palsy, and related neurological conditions. It is a modification of the classic "Qianzheng San" formula, which typically consists of *Typhonium giganteum* (Bai Fu Zi), *Bombyx mori* (Jiang Can), and *Buthus martensii* (Quan Xie). The addition of *Bupleurum chinense* (Chaihu) is intended to soothe the liver, regulate Qi, and guide the other medicinal components to the Shaoyang meridian, which is often involved in facial nerve disorders. The formula works by dispelling wind, resolving phlegm, and unblocking the meridians to restore facial muscle function. Pharmacologically, it is thought to exert anti-inflammatory and neuroprotective effects, promoting the recovery of the facial nerve and improving local microcirculation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chaihu Qianzheng San.